Tumor-specific deposition of immunoglobulin G and complement in papillary thyroid carcinoma

被引:79
作者
Lucas, SD
KarlssonParra, A
Nilsson, B
Grimelius, L
Akerstrom, G
Rastad, J
Juhlin, C
机构
[1] UPPSALA UNIV,DEPT SURG,ENDOCRINE SURG RES UNIT,UPPSALA,SWEDEN
[2] UPPSALA UNIV,DEPT CLIN IMMUNOL,UPPSALA,SWEDEN
[3] UPPSALA UNIV,DEPT PATHOL,UPPSALA,SWEDEN
关键词
papillary thyroid carcinoma; immunoglobulin G; classical complement pathway; tumor antigens; thyroid diseases;
D O I
10.1016/S0046-8177(96)90346-9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Despite its predilection for multifocal growth and regional metastasis, papillary thyroid carcinoma (PTC) is a clinically indolent malignancy with an exceptionally favorable long-term prognosis. Together with the often striking inflammatory reaction present in PTC, its quiescent behavior has been suggested to reflect the activation of a tumor-induced immune response. To examine this possibility, eve have studied the deposition of immunoglobulins and complement in PTC tissue. Samples from 70 cases of neoplastic and autoimmune thyroid diseases, including PTC (n = 41), follicular, anaplastic, and medullary carcinomas (n = 12), follicular adenoma (n = 6), Graves' disease (n = 8), and Hashimoto's thyroiditis (n = 3) were analyzed immunohistochemically. Cellular deposits of immunoglobulin G (IgG), particularly subclasses IgG(1) and IgG(4), and complement factors C3d, C4d, and C5 were shown in up to 89% of the PTC cases, whereas the other thyroid diseases studied showed little or no cellular deposition. Nonneoplastic tissue of PTC-containing thyroid glands (n = 22) lacked staining for IgG in 50% of the cases, and 82% were devoid of complement. The results suggest a tumor-specific immune response in PTC with activation of the classical complement cascade. Copyright (C) 1996 by W.B. Saunders Company
引用
收藏
页码:1329 / 1335
页数:7
相关论文
共 47 条
[1]  
AIN KB, 1991, ANN INTERN MED, V115, P133
[2]  
BARRETT DJ, 1986, CLIN EXP IMMUNOL, V63, P127
[3]   THE BINDING-AFFINITY OF HUMAN-IGG FOR ITS HIGH-AFFINITY FC RECEPTOR IS DETERMINED BY MULTIPLE AMINO-ACIDS IN THE CH2 DOMAIN AND IS MODULATED BY THE HINGE REGION [J].
CANFIELD, SM ;
MORRISON, SL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (06) :1483-1491
[4]   RELATION OF THYROID NEOPLASMS TO HASHIMOTO DISEASE OF THE THYROID GLAND [J].
DAILEY, ME ;
LINDSAY, S ;
SKAHEN, R .
ARCHIVES OF SURGERY, 1955, 70 (02) :291-297
[5]   RESTRICTED HETEROGENEITY AND T-CELL DEPENDENCE OF HUMAN THYROID AUTOANTIBODY IMMUNOGLOBULIN-G SUBCLASSES [J].
DAVIES, TF ;
WEBER, CM ;
WALLACK, P ;
PLATZER, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1986, 62 (05) :945-949
[6]   CLINICAL OUTCOME OF COLORECTAL-CANCER PATIENTS TREATED WITH HUMAN MONOCLONAL ANTIIDIOTYPIC ANTIBODY [J].
DENTON, GWL ;
DURRANT, LG ;
HARDCASTLE, JD ;
AUSTIN, EB ;
SEWELL, HF ;
ROBINS, RA .
INTERNATIONAL JOURNAL OF CANCER, 1994, 57 (01) :10-14
[7]   HUMAN ANTIIDIOTYPIC ANTIBODIES INDUCED A HUMORAL AND CELLULAR IMMUNE-RESPONSE AGAINST A COLORECTAL CARCINOMA-ASSOCIATED ANTIGEN IN PATIENTS [J].
FAGERBERG, J ;
STEINITZ, M ;
WIGZELL, H ;
ASKELOF, P ;
MELLSTEDT, H .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (11) :4773-4777
[8]   TARGETING ANTIGEN INTO THE PHAGOCYTIC PATHWAY IN-VIVO INDUCES PROTECTIVE TUMOR-IMMUNITY [J].
FALO, LD ;
KOVACSOVICSBANKOWSKI, M ;
THOMPSON, K ;
ROCK, KL .
NATURE MEDICINE, 1995, 1 (07) :649-653
[9]  
GRAZIANO RF, 1989, IMMUNOL TODAY, V10, P92
[10]   HIGH EXPRESSION RATE OF TN ANTIGEN IN METASTATIC LESIONS OF UTERINE CERVICAL CANCERS [J].
HAMADA, S ;
FURUMOTO, H ;
KAMADA, M ;
HIRAO, T ;
AONO, T .
CANCER LETTERS, 1993, 74 (03) :167-173